3651 results for «217»

Filter By

3651 results

Overcoming complications with intracoronary imaging

21 May 2026 – From EuroPCR 2026

Explore challenging cases of intracoronary imaging complications, highlighting recognition, management, and resolution of complex vascular and mechanical issues encountered during coronary interventions.

Atypical NSTEMI culprit lesions

22 May 2026 – From EuroPCR 2026

Focusing on atypical NSTEMI culprit lesions, this session examines rare presentations such as calcific emboli, coronary anomalies, and unusual routes to revascularisation. It provides clinical insights into diagnosing and managing uncommon acute coronary syndromes effectively.

Clinical decision making for CTO PCI strategy

22 May 2026 – From EuroPCR 2026

This session explores clinical decision-making in CTO PCI strategy through complex scenarios including multivessel CTO in ischemic cardiomyopathy, high-risk NSTEMI post-vein graft failure, and challenges in elderly patients. It emphasizes strategic planning and individualized approaches to optimize outcomes.

Spontaneous coronary artery dissection management with intracoronary imaging

22 May 2026 – From EuroPCR 2026

Explore the nuanced management of spontaneous coronary artery dissection (SCAD) with a focus on intracoronary imaging. This session examines diagnostic challenges, the limited role of coronary CT angiography, and strategies for managing occlusive SCAD cases, highlighting the evolving understanding of this complex condition.

Diversity in coronary artery disease treatment

22 May 2026 – From EuroPCR 2026

Focusing on the diversity in coronary artery disease treatment, this session highlights challenges ranging from maintaining interventional cardiology services during conflict to the influence of comorbidities such as type 2 diabetes mellitus on prognosis and risk assessment. It also presents clinical outcomes related to stent thrombosis...

Left main PCI-complex procedures

22 May 2026 – From EuroPCR 2026

This session covers complex left main coronary artery PCI procedures that challenge standard algorithms. It includes tackling chronic total occlusions of the left main, managing spontaneous coronary artery dissection in patients on ECMO, handling stent dislodgement, and addressing complex trifurcation lesions, providing comprehensive insights into advanced...

Calcified lesions: when one dedicated device is not enough

22 May 2026 – From EuroPCR 2026

This session highlights the need for multiple dedicated devices in the treatment of calcified coronary lesions. It discusses combined orbital and rotational atherectomy techniques, debulking in complex high-risk patients, and the integration of atherectomy with intravascular lithotripsy systems. Emphasis is placed on physiology and imaging-guided approaches...

Innovative strategies in STEMI management

22 May 2026 – From EuroPCR 2026

This session presents innovative strategies in STEMI management, including the treatment of acute saphenous vein graft occlusion, primary PCI via the left internal mammary artery, and a two-step lesion debulking approach. It also covers hybrid drug-coated balloon strategies in complex multivessel disease and the emerging role...

PANTHER - P2Y12 inhibitor versus aspirin monotherapy in patients with coronary artery disease

30 Aug 2022

Elad Asher provides his take on the PANTHER trial which was presented at the ESC Congress 2022 in Barcelona

Elad Asher

Author

Elad Asher
PANTHER - P2Y12 inhibitor versus aspirin monotherapy in patients with coronary artery disease

TRIGISTRY: Benefit of isolated surgical valve repair or replacement for functional tricuspid regurgitation and long-term outcomes stratified by the TRI-SCORE

31 Aug 2024

Alex Sticchi provides his take on the TRIGISTRY study presented by Julien Dreyfus at the ESC Congress 2024 in London.

Simultaneous publication in European Heart Journal, ehae578

Alessandro Sticchi

Author

Alessandro Sticchi
Benefit of isolated surgical valve repair or replacement for functional TR and long-term outcomes

EuroPCR 2024: Elixir Medical’s late-breaking 12-month data demonstrate significant improvement in safety and effectiveness of world’s first site-specific antithrombotic therapeutic compared to DES

14 May 2024

Didn’t find what you were looking for?